{{Rsnum
|rsid=4961252
|Chromosome=8
|position=141094845
|Orientation=plus
|GMAF=0.4449
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 46.9 | 14.2
| HCB | 11.1 | 45.2 | 43.7
| JPT | 11.8 | 49.1 | 39.1
| YRI | 2.1 | 36.1 | 61.8
| ASW | 10.7 | 51.8 | 37.5
| CHB | 11.1 | 45.2 | 43.7
| CHD | 8.3 | 45.4 | 46.3
| GIH | 21.8 | 51.5 | 26.7
| LWK | 6.5 | 34.3 | 59.3
| MEX | 28.1 | 54.4 | 17.5
| MKK | 10.3 | 50.6 | 39.1
| TSI | 40.6 | 42.6 | 16.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21502966
|Trait=None
|Title=Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-Î² therapy in multiple sclerosis patients.
|RiskAllele=G
|Pval=3E-8
|OR=0.2300
|ORtxt=[NR] unit increase
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}